| Lindsay C Stanley, PA | |
|
736 Cambridge St, Brighton, MA 02135-2907 | |
| (617) 789-2696 | |
| Not Available |
| Full Name | Lindsay C Stanley |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 14 Years |
| Location | 736 Cambridge St, Brighton, Massachusetts |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083902811 | NPI | - | NPPES |
| PA4091 | Other | MA | LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363AM0700X | Physician Assistant - Medical | PA4091 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Carney Hospital | Boston, MA | Hospital |
| St Elizabeth's Medical Center | Brighton, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Steward Medical Group Inc | 2860688728 | 1404 |
News Archive
Experts from PAREXEL International Corporation, a leading global biopharmaceutical services provider, will provide insights into evolving pharmacovigilance trends and their impact on biosimilars and generic products at the World Generic Medicines Congress Americas, being held November 17 - 20, 2009 in Washington, DC.
The lightning speed with which scientists developed and tested the COVID-19 vaccine is a true scientific triumph - one that would not have been possible without the more than 70,000 volunteers who participated in clinical trials of the vaccine.
Actavis plc today announced that its subsidiary Forest Laboratories, LLC has successfully completed its acquisition of Furiex Pharmaceuticals, Inc. in an all-cash transaction valued at approximately $1.1 billion, and up to approximately $360 million in a Contingent Value Right (CVR) that may be payable based on the status of eluxadoline, Furiex's lead product, as a controlled drug following approval.
Achillion Pharmaceuticals, Inc., a leader in the discovery and development of small molecule drugs to combat the most challenging infectious diseases, today reported financial results for the three and twelve months ended December 31, 2009.
A faculty-student research team in the chemistry lab at the University of Redlands has advanced a new approach to a critical process in pharmaceutical drug development that could reduce the time and cost of bringing a drug from concept to market.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lindsay C Stanley, PA 736 Cambridge St, Brighton, MA 02135-2907 Ph: (617) 789-2696 | Lindsay C Stanley, PA 736 Cambridge St, Brighton, MA 02135-2907 Ph: (617) 789-2696 |
News Archive
Experts from PAREXEL International Corporation, a leading global biopharmaceutical services provider, will provide insights into evolving pharmacovigilance trends and their impact on biosimilars and generic products at the World Generic Medicines Congress Americas, being held November 17 - 20, 2009 in Washington, DC.
The lightning speed with which scientists developed and tested the COVID-19 vaccine is a true scientific triumph - one that would not have been possible without the more than 70,000 volunteers who participated in clinical trials of the vaccine.
Actavis plc today announced that its subsidiary Forest Laboratories, LLC has successfully completed its acquisition of Furiex Pharmaceuticals, Inc. in an all-cash transaction valued at approximately $1.1 billion, and up to approximately $360 million in a Contingent Value Right (CVR) that may be payable based on the status of eluxadoline, Furiex's lead product, as a controlled drug following approval.
Achillion Pharmaceuticals, Inc., a leader in the discovery and development of small molecule drugs to combat the most challenging infectious diseases, today reported financial results for the three and twelve months ended December 31, 2009.
A faculty-student research team in the chemistry lab at the University of Redlands has advanced a new approach to a critical process in pharmaceutical drug development that could reduce the time and cost of bringing a drug from concept to market.
› Verified 6 days ago
Ms. Joanna M Gross, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 736 Cambridge St, Brighton, MA 02135 Phone: 617-789-5004 | |
Eric Yenulevich, PA Physician Assistant Medicare: Medicare Enrolled Practice Location: 736 Cambridge St, Brighton, MA 02135 Phone: 617-789-3000 Fax: 617-562-5415 | |
Kara Elizabeth Burlbaugh, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 2039 Commonwealth Ave Apt 12, Brighton, MA 02135 Phone: 724-672-2181 | |
Marjorie Jimenez, P.A. Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 45 Lane Park, Brighton, MA 02135 Phone: 617-254-3326 | |
Nicholas Biadasz, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 736 Cambridge St, Brighton, MA 02135 Phone: 617-789-3000 | |
Ms. Sharon M. Kaden, PA Physician Assistant Medicare: Medicare Enrolled Practice Location: 736 Cambridge Street, Brighton, MA 02135 Phone: 617-632-6464 |